ALERT HAN Messages

The Alabama Department of Public Health (ADPH) has created the Alabama Emergency Response Technology (ALERT) to push health alert network (HAN) messages via email to healthcare providers statewide. ALERT HAN and FDA messages are intended to keep healthcare providers updated on new or emerging healthcare-related situations. ADPH will also send out the Centers for Disease Control and Prevention (CDC) HAN messages using ALERT.

If traveling out of the country, review CDC Travel Health Notices.

Table of Contents

• ADPH ALERT Messages
• CDC HAN Messages

View ADPH HAN Alert and CDC HAN Alert Archives

ADPH ALERT Messages

05/06/22
Temporary Shortage of Contrast Media

05/02/22
Modifications to Reporting Requirements for Negative SARS-CoV-2 Antigen Results

04/28/22
Updated Information on Availability and Use of Treatments for Outpatients with Mild to Moderate COVID -19 Who are at Increased Risk for Severe Outcomes of COVID-19

04/21/22
Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology Summary

04/07/22
Distribution of Sotrovimab Paused to All HHS Regions

03/17/22
Free CME Training Available-University of Alabama at Birmingham (UAB) Sanitation Health Study

02/14/22
Centers for Disease Control and Prevention (CDC) Updates COVID-19 Vaccination
Guidance

02/14/22
United States Food and Drug Administration (FDA) authorizes Eli Lilly’s COVID-19
Monoclonal Antibody Drug Bebtelovimab

02/01/22
Call to Report: Providers Encouraged to Report Certain Symptomatic Patients with
Adenovirus Infections

01/25/22
FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to Omicron Variant

01/10/2022
Limited Therapeutic Options for Outpatient Treatment of COVID-19

01/07/2022
FDA Amends EUA for COMIRNATY/Pfizer-BioNTech and Moderna mRNA Vaccines and CDC/ACIP Endorses New Recommendations

01/03/2022
Monoclonal Antibody Update: Paused Monoclonal Antibodies for Treatment of COVID-19 Disease Available Again

12/30/2021
FDA Issues Emergency Use Authorization for Paxlovid to Treat COVID-19 Infection

12/30/2021
Monoclonal Antibody Update: Effectiveness Against COVID-19 Omicron Variant

12/28/2021
COVID-19 Update for Hospitals and Healthcare Personnel

12/20/2021
COVID-19 omicron variant may negatively affect the test results of currently used COVID-19 tests

11/03.2021
CDC Recommends Pediatric COVID-19 Vaccine for Children 5 through 11 Years Old

10/22/2021
CDC Expands Eligibility for COVID-19 Vaccine Booster Shots

09/29/2021
Clarification on Physician Order and mRNA Vaccine Attestation For Use
COVID-19 Vaccination for Pregnant People to Prevent Serious Illness, Deaths, and Adverse Pregnancy Outcomes from COVID-19

09/24/2021
FDA Authorizes Pfizer's COVID-19 Booster for People Over 65 or at High Risk

09/15/2021
Immediate Change to HHS' COVID-19 Monoclonal Antibody Ordering Process

09/08/2021
COVID-19 Update on Availability of Monoclonal Antibody Treatment

09/01/2021
Sexually Transmitted Infection Treatment Guidelines, 2021

08/25/2021
Warning Issued by Federal Drug Administration (FDA) and World Health Organization (WHO) on Use of Ivermectin

08/24/2021
FDA Approves COMIRNATY (COVID-19 vaccine, mRNA) Previously Known as Pfizer-NTech

08/23/2021
COVID-19 Vaccination for Pregnant Individuals

08/16/2021
3rd Dose mRNA COVID-19 Vaccine in Immunocompromised and Use of Monoclonal Antibodies for High Risk Patients/Additional 3rd Dose of Pfizer or Moderna COVID-19 Vaccine for Immunocompromised

08/05/2021
Alabama Hospital Emergency Rooms Seeing Patient Surge

07/28/2021
COVID-19 Masking Update and the Delta Variant

07/22/2021
COVID-19 Update on Testing, Sequencing and Non-hospitalized Patient Treatment

05/13/2021
ADPH Calls for Children and Teens age 12 and up to get the COVID-19 Vaccine

04/30/2021
Providers Resume Use of the J&J/Janssen COVID-19 Vaccine

04/15/2021
ACIP Requests Continued Pause on Use of J & J Vaccine

04/13/2021
CDC and FDA Request Pause on Use of J & J Vaccine

03/23/2021
Increase in Perinatal HIV Cases in Alabama

02/19/2021
Updated Alabama Department of Public Health COVID-19 Non-Healthcare Isolation and Quarantine Guidance

01/29/2021
A Devastating Surge in Congenital Syphilis in Alabama

01/27/2021
Updated Gonorrhea Treatment Recommendations

12/31/20
Obtaining COVID-19 Vaccinations

12/11/20
Updated Isolation and Quarantine Timeframes for COVID-19 for Non-Healthcare Personnel

 

 

CDC HAN Messages

05/20/22
Monkeypox Virus Infection in the United States and Other Non-endemic Countries --- 2022

05/11/22
Updated Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology

04/25/22
Updated Information on Availability and Use of Treatments for Outpatients with Mild to Moderate COVID-19 Who are at Increased Risk for Severe Outcomes of COVID-19

04/21/22
Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology

12/31/2021
Using Therapeutics to Prevent and Treat COVID-19

12/24/2021
Rapid Increase of Omicron Variant Infections in the United States: Management of Healthcare Personnel with SARS-CoV-2 Infection or Exposure

12/01/2021
New SARS-CoV-2 Variant of Concern Identified: Omicron (B.1.1.529) Variant

11/24/2021
Increasing Seasonal Influenza A (H3N2) Activity, Especially Among Young Adults and in College and University Settings, During SARS-CoV-2 Circulation

11/05/2021
Update: Expansion of Recall of LeadCare Blood Lead Tests Due to Risk of Falsely Low Results

11/03/2021
Source Identified and Case Definition Established: Multistate Investigation of Non-travel Associated Burkholderia pseudomallei Infections (Melioidosis) in Four Patients: Georgia, Kansas, Minnesota, and Texas – 2021

10/22/2021
Source Implicated in Fatal Case in Georgia: Multistate Outbreak of Non-travel Associated Burkholderia pseudomallei Infections (Melioidosis) in Four Patients: Georgia, Kansas, Minnesota, and Texas –2021

10/22/2021
Pfizer-BioNTech, Moderna, and Janssen COVID-19 Vaccine Booster Dose Recommendations

10/14/2021
Expansion of Recall of LeadCare Blood Lead Tests Due to Risk of Falsely Low Results

09/29/2021
COVID-19 Vaccination for Pregnant People to Prevent Serious Illness, Deaths, and Adverse Pregnancy Outcomes from COVID-19

09/20/2021
Guidance for Clinicians Caring for Individuals Recently Evacuated from Afghanistan

09/14/2021
Increases in Availability of Cannabis Products Containing Delta-8 THC and Reported Cases of Adverse Events

08/28/2021
Hurricane Ida—Clinical Guidance for Carbon Monoxide (CO) Poisoning

08/26/2021
Rapid Increase in Ivermectin Prescriptions and Reports of Severe Illness Associated with Use of Products Containing Ivermectin to Prevent or Treat COVID-19

08/09/2021
New Case Identified: Multistate Investigation of Non-travel Associated Burkholderia pseudomallei Infections (Melioidosis) in Four Patients: Georgia, Kansas, Minnesota, and Texas—2021

07/27/2021
Vaccination to Prevent COVID-19 Outbreaks with Current and Emergent Variants — United States, 2021

07/17/2021
Potential Exposure to Person with Confirmed Human Monkeypox Infection — United States, 2021

07/06/2021
Recall of LeadCare® Blood Lead Tests Due to Risk of Falsely Low Results

06/30/2021
Multistate Investigation of Non-travel Associated Burkholderia pseudomallei Infections (Melioidosis) in Three Patients: Kansas, Texas, and Minnesota—2021

06/10/2021
Increased Interseasonal Respiratory Syncytial Virus (RSV) Activity in Parts of the Southern United States

04/13/2021
Cases of Cerebral Venous Sinus Thrombosis with Thrombocytopenia after Receipt of the Johnson & Johnson COVID-19 Vaccine

03/31/2021
Acute Non-Viral Hepatitis of Unknown Etiology Potentially Associated with an Alkaline Water Product

02/17/2021
2021 Winter Storms—Clinical Guidance for Carbon Monoxide (CO) Poisoning

02/12/2021
Extensively Drug-Resistant Salmonella Typhi Infections Among U.S. Residents Without International Travel